Logo image of IVC

INVACARE CORP (IVC) Stock Fundamental Analysis

USA - NYSE:IVC - US4612031017 - Common Stock

0.6598 USD
-0.02 (-2.25%)
Last: 1/31/2023, 8:04:00 PM
0.53 USD
-0.13 (-19.67%)
Pre-Market: 2/1/2023, 8:00:01 AM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to IVC. IVC was compared to 190 industry peers in the Health Care Equipment & Supplies industry. IVC has a bad profitability rating. Also its financial health evaluation is rather negative. IVC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

IVC had negative earnings in the past year.
In the past year IVC has reported a negative cash flow from operations.
IVC Yearly Net Income VS EBIT VS OCF VS FCFIVC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M -40M -60M

1.2 Ratios

The profitability ratios for IVC are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVC Yearly ROA, ROE, ROICIVC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -5 -10 -15 -20

1.3 Margins

Looking at the Gross Margin, with a value of 24.21%, IVC is doing worse than 77.78% of the companies in the same industry.
In the last couple of years the Gross Margin of IVC has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for IVC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5Y0.24%
IVC Yearly Profit, Operating, Gross MarginsIVC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 20

More info and screens

1

2. Health

2.1 Basic Checks

IVC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IVC has more shares outstanding
IVC has a worse debt/assets ratio than last year.
IVC Yearly Shares OutstandingIVC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
IVC Yearly Total Debt VS Total AssetsIVC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.90, we must say that IVC is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.90, IVC is in line with its industry, outperforming 47.22% of the companies in the same industry.
IVC has a Debt/Equity ratio of 4.82. This is a high value indicating a heavy dependency on external financing.
IVC has a worse Debt to Equity ratio (4.82) than 88.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.82
Debt/FCF N/A
Altman-Z 0.9
ROIC/WACCN/A
WACC5.71%
IVC Yearly LT Debt VS Equity VS FCFIVC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.32 indicates that IVC should not have too much problems paying its short term obligations.
IVC has a worse Current ratio (1.32) than 85.65% of its industry peers.
A Quick Ratio of 0.78 indicates that IVC may have some problems paying its short term obligations.
IVC has a worse Quick ratio (0.78) than 87.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.78
IVC Yearly Current Assets VS Current LiabilitesIVC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for IVC have decreased strongly by -137.21% in the last year.
IVC shows a decrease in Revenue. In the last year, the revenue decreased by -9.61%.
IVC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.59% yearly.
EPS 1Y (TTM)-137.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-666.67%
Revenue 1Y (TTM)-9.61%
Revenue growth 3Y-3.55%
Revenue growth 5Y-3.59%
Sales Q2Q%-23.99%

3.2 Future

IVC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.14% yearly.
IVC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.30% yearly.
EPS Next Y-309.94%
EPS Next 2Y-41.08%
EPS Next 3Y1.14%
EPS Next 5YN/A
Revenue Next Year-16.76%
Revenue Next 2Y-8.92%
Revenue Next 3Y-0.3%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IVC Yearly Revenue VS EstimatesIVC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
IVC Yearly EPS VS EstimatesIVC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

IVC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IVC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IVC Price Earnings VS Forward Price EarningsIVC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVC Per share dataIVC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.08%
EPS Next 3Y1.14%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IVC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INVACARE CORP

NYSE:IVC (1/31/2023, 8:04:00 PM)

Premarket: 0.53 -0.13 (-19.67%)

0.6598

-0.02 (-2.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07 2022-11-07/amc
Earnings (Next)03-06 2023-03-06/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners8.6%
Ins Owner Change0%
Market Cap24.91M
Revenue(TTM)786.60M
Net Income(TTM)-78556000
Analysts83.33
Price Target1.68 (154.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-90.87%
Min EPS beat(2)-135.57%
Max EPS beat(2)-46.16%
EPS beat(4)1
Avg EPS beat(4)19.93%
Min EPS beat(4)-135.57%
Max EPS beat(4)296.04%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-12.25%
Min Revenue beat(2)-14.37%
Max Revenue beat(2)-10.12%
Revenue beat(4)1
Avg Revenue beat(4)-7.59%
Min Revenue beat(4)-14.37%
Max Revenue beat(4)0.78%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-49.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-111.54%
EPS NY rev (1m)0%
EPS NY rev (3m)-43.5%
Revenue NQ rev (1m)-1.36%
Revenue NQ rev (3m)-14.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.31
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.04
EYN/A
EPS(NY)-1.35
Fwd EYN/A
FCF(TTM)-0.82
FCFYN/A
OCF(TTM)-0.65
OCFYN/A
SpS20.83
BVpS2.15
TBVpS-6.81
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.21%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5Y0.24%
F-Score3
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 4.82
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 41%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.78
Altman-Z 0.9
F-Score3
WACC5.71%
ROIC/WACCN/A
Cap/Depr(3y)110.34%
Cap/Depr(5y)98.77%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-137.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-666.67%
EPS Next Y-309.94%
EPS Next 2Y-41.08%
EPS Next 3Y1.14%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.61%
Revenue growth 3Y-3.55%
Revenue growth 5Y-3.59%
Sales Q2Q%-23.99%
Revenue Next Year-16.76%
Revenue Next 2Y-8.92%
Revenue Next 3Y-0.3%
Revenue Next 5YN/A
EBIT growth 1Y-4083.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-562.49%
EBIT Next 3Y89.23%
EBIT Next 5Y54.07%
FCF growth 1Y-151.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-397.05%
OCF growth 3YN/A
OCF growth 5YN/A